These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11490778)

  • 1. [Characteristic perfusion pattern of osseous giant cell tumor in dynamic contrast-enhanced MRI].
    Libicher M; Bernd L; Schenk JP; Mädler U; Grenacher L; Kauffmann GW
    Radiologe; 2001 Jul; 41(7):577-82. PubMed ID: 11490778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triple-phase dynamic MRI: a new clue to predict malignant transformation of giant cell tumor of bone.
    Chen L; Ding XY; Wang CS; Si MJ; Du LJ; Lu Y
    Eur J Radiol; 2014 Feb; 83(2):354-9. PubMed ID: 24239410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphological and dynamic contrast enhanced MR imaging features for the differentiation of chordoma and giant cell tumors in the Axial Skeleton.
    Lang N; Su MY; Xing X; Yu HJ; Yuan H
    J Magn Reson Imaging; 2017 Apr; 45(4):1068-1075. PubMed ID: 27490009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From the archives of AFIP. Imaging of giant cell tumor and giant cell reparative granuloma of bone: radiologic-pathologic correlation.
    Murphey MD; Nomikos GC; Flemming DJ; Gannon FH; Temple HT; Kransdorf MJ
    Radiographics; 2001; 21(5):1283-309. PubMed ID: 11553835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging.
    Uhl M; Saueressig U; van Buiren M; Kontny U; Niemeyer C; Köhler G; Ilyasov K; Langer M
    Invest Radiol; 2006 Aug; 41(8):618-23. PubMed ID: 16829744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [High dosage Gd-DPTA-BMA (Gadodiamid) administration in diagnosis and therapeutic monitoring of malignant bone tumors].
    Häussler MD; Rummeny EJ; Raufhake C; Blasius S; Lindner N; Daldrup HE; Reimer P; Peters PE
    Radiologe; 1996 Feb; 36(2):148-52. PubMed ID: 8867432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for recurrence of giant cell tumours of bone.
    Siddiqui MA; Seng C; Tan MH
    J Orthop Surg (Hong Kong); 2014 Apr; 22(1):108-10. PubMed ID: 24781627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of the risk factors for local recurrence of giant cell tumor of long bone].
    Xu H; Niu X
    Zhonghua Zhong Liu Za Zhi; 2014 Jun; 36(6):465-8. PubMed ID: 25241792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease.
    Seeger A; Braun C; Skardelly M; Paulsen F; Schittenhelm J; Ernemann U; Bisdas S
    Acad Radiol; 2013 Dec; 20(12):1557-65. PubMed ID: 24200483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gadolinium-enhanced MRI with dynamic evaluation in diagnosing the local recurrence of rectal cancer.
    Torricelli P; Pecchi A; Luppi G; Romagnoli R
    Abdom Imaging; 2003; 28(1):19-27. PubMed ID: 12483379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological Features of a Series of 27 Cases of Post-Denosumab Treated Giant Cell Tumors of Bones: A Single Institutional Experience at a Tertiary Cancer Referral Centre, India.
    Rekhi B; Verma V; Gulia A; Jambhekar NA; Desai S; Juvekar SL; Bajpai J; Puri A
    Pathol Oncol Res; 2017 Jan; 23(1):157-164. PubMed ID: 27722984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Giant Cell Tumor (tumor gigantocellularis, osteoclastoma) - epidemiology, diagnosis, treatment.
    Karpik M
    Ortop Traumatol Rehabil; 2010; 12(3):207-15. PubMed ID: 20675862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors of local recurrence of giant cell tumor of long bone after treatment: plain radiographs, pathology and surgical procedures.
    Chanchairujira K; Jiranantanakorn T; Phimolsarnti R; Asavamongkolkul A; Waikakul S
    J Med Assoc Thai; 2011 Oct; 94(10):1230-7. PubMed ID: 22145509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Surgical treatment for long bone giant cell tumor of extremity with pathologic fracture].
    Li X; Guo W; Yang Y; Wei R; DU ZY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Oct; 45(5):745-51. PubMed ID: 24136271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic contrast-enhanced magnetic resonance imaging of the breast combined with pharmacokinetic analysis of gadolinium-DTPA uptake in the diagnosis of local recurrence of early stage breast carcinoma.
    Mussurakis S; Buckley DL; Bowsley SJ; Carleton PJ; Fox JN; Turnbull LW; Horsman A
    Invest Radiol; 1995 Nov; 30(11):650-62. PubMed ID: 8557506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathology of giant cell tumors of the bone: With special emphasis on fibrohistiocytic and aneurysmal bone cyst like components.
    Çomunoğlu N; Kepil N; Dervişoğlu S
    Acta Orthop Traumatol Turc; 2019 Jan; 53(1):35-39. PubMed ID: 30392920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [MR-Imaging of lower leg muscle perfusion].
    Leppek R; Hoos O; Sattler A; Kohle S; Azzam S; Al Haffar I; Keil B; Ricken P; Klose KJ; Alfke H
    Herz; 2004 Feb; 29(1):32-46. PubMed ID: 14968340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of perfusion in normal carpal bones with dynamic gadolinium-enhanced MRI at 3 Tesla.
    Müller GM; Månsson S; Müller MF; Ekberg O; Björkman A
    J Magn Reson Imaging; 2013 Jul; 38(1):168-72. PubMed ID: 23188589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence of a primary malignant giant cell tumour of bone 14 years after initial surgery.
    Merad M; Mesurolle B; Guinebretière JM; Lecesne A; Missenard G; Vanel D
    Eur Radiol; 2001; 11(8):1483-6. PubMed ID: 11519561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absolute quantification of regional renal blood flow in swine by dynamic contrast-enhanced magnetic resonance imaging using a blood pool contrast agent.
    Lüdemann L; Nafz B; Elsner F; Grosse-Siestrup C; Meissler M; Kaufels N; Rehbein H; Persson PB; Michaely HJ; Lengsfeld P; Voth M; Gutberlet M
    Invest Radiol; 2009 Mar; 44(3):125-34. PubMed ID: 19151609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.